Category: New products
-

Urine Test Shows Promise for Cancer Screening
Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer.
-

Deep Learning Techniques Speed Drug Discovery
Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days.
-

Chip Device Simulates Islet Cell Functions
A new device testing the functions of insulin-producing islet cells in the pancreas is designed on a plastic chip made with common materials and manufacturing methods.
-

Robotic Device Navigates Brain Blood Vessels
Engineers and materials scientists designed a robotic device thin and flexible enough to thread through blood vessels in a model brain under remote control.
-

Patch Designed for Vaccines, Cancer Treatments
An engineering team designed a small skin patch with tiny needles that in lab mice quickly delivers vaccines and possibly treatments for melanoma.
-

Crispr Deployed for Programmable Smart Hydrogels
Bio-engineers developed a process using the gene editing technique Crispr to design gel materials with properties added for drug delivery, diagnostics, and electronic circuits.
-

Small Biz Grant Funds Pre-Term Gut Microbe Therapy
National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants.
-

Carb-X Funds Drug-Resistant Bacterial Vaccine
A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria.
-

Optic Nerve Stimulation Developed as Visual Prosthetic
Engineers in Europe developed an electronic device that connects to and stimulates the optic nerve, producing simple visual patterns in lab animals.
-

FDA Okays Celiac Disease Engineered Microbe Trial
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease.